Advertisement
Broad Institute Emerges Victorious In Patent Fight Over CRISPR Gene-Editing Tech
ResumeOn Wednesday, the U.S. Patent and Trademark Office ruled that MIT's Feng Zhang and his team of bio-tech scientists at the Broad Institute of MIT and Harvard can keep their patents for their work on CRISPR gene-editing technology.
For more on this ruling and its implications, patent expert Paul Gugliuzza joined Morning Edition.
This segment aired on February 16, 2017.